| Type 2 Diabetes Mellitus |
| Improves glycemic control |
| Combination therapy for insulin resistance and beta-cell dysfunction |
Tablet
Glibenclamide is a sulfonylurea antidiabetic drug indicated for the treatment of type 2 diabetes mellitus. It lowers blood glucose by stimulating insulin secretion from pancreatic beta cells.
| Speciality | Endocrinology | Diabetology | General Medicine |
|---|---|
| Tags | Sulfonylurea | Type 2 Diabetes | Blood Sugar Control |
| Strength |
|
| Packing Size |
|
All product details on this website are for reference and informational purposes only and
are not directed at patients or consumers.
As a contract manufacturer,
DM Pharma Pvt Ltd is not responsible for the marketing or end use of these products and disclaims all
liability arising from reliance on this information.
Please consult a healthcare professional before
using any medicinal product.